IP Library › Patent Application 63050147
Patent Application Provisional
App. No. 63/050,147 · Confirmation No. 9569

COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF ENDOTHELIN RELATED DISEASES

Applicant: AstraZeneca AB
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2023-05-04 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2023-05-04 APP.FILE.REC Filing Receipt 3 View
2023-05-02 R48.REQ Request under Rule 48 correcting inventorship 3 View
2023-05-02 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-05-02 ADS Application Data Sheet 10 View
2023-05-02 N417.PYMT Electronic Fee Payment 2 View
2020-11-06 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2020-11-03 PA.. Power of Attorney 1 View
2020-11-03 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-10-08 APP.FILE.REC Filing Receipt 3 View
2020-09-02 WFEE Fee Worksheet (SB06) 2 View
2020-09-02 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-07-16 APP.FILE.REC Filing Receipt 3 View
2020-07-16 NTC.MISS.PRT Notice to File Missing Parts 2 View
2020-07-10 ADS Application Data Sheet 9 View
2020-07-10 SPEC Specification 32 View
2020-07-10 CLM Claims 2 View
2020-07-10 ABST Abstract 1 View
2020-07-10 DRW Drawings-only black and white line drawings 6 View
2020-07-10 WFEE Fee Worksheet (SB06) 2 View
2020-07-10 N417 Electronic Filing System Acknowledgment Receipt 2 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/050,147
Filed
2020-07-10